Detalles de la búsqueda
1.
Clinical characteristics limiting the durability of humoral response to BNT162b2 in patients with solid cancer.
Ann Oncol
; 33(3): 350-352, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34861377
2.
Potentiation of humoral response to the BNT162b2 vaccine after the third dose in patients with solid cancer.
Ann Oncol
; 33(5): 563-565, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35202794
3.
A Phase II, randomized, double-blind study of zibotentan (ZD4054) in combination with carboplatin/paclitaxel versus placebo in combination with carboplatin/paclitaxel in patients with advanced ovarian cancer sensitive to platinum-based chemotherapy (AGO-OVAR 2.14).
Gynecol Oncol
; 130(1): 31-7, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23234805
4.
Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial.
Ann Oncol
; 23(3): 695-700, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21859900
5.
Lack of growth inhibitory synergism with combined MAPK/PI3K inhibition in preclinical models of pancreatic cancer.
Ann Oncol
; 28(11): 2896-2898, 2017 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28666315
6.
Retreatment with trastuzumab-based therapy after disease progression following lapatinib in HER2-positive metastatic breast cancer.
Ann Oncol
; 23(6): 1436-41, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22039084
7.
Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis.
Ann Oncol
; 22(10): 2277-85, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21325444
8.
Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine.
Ann Oncol
; 22(3): 625-630, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20724575
9.
Radical metastasectomy followed by sorafenib versus observation in patients withclear cell renal cell carcinoma: extended follow -up of efficacy results from the randomized phase II RESORT trial.
Expert Rev Clin Pharmacol
; 14(2): 261-268, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33472450
10.
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study.
ESMO Open
; 6(2): 100099, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33819752
11.
Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial.
Br J Cancer
; 103(10): 1542-7, 2010 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-20959822
12.
In situ protein expression of RRM1, ERCC1, and BRCA1 in metastatic breast cancer patients treated with gemcitabine-based chemotherapy.
Cancer Invest
; 28(2): 172-80, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19968494
13.
Clinical significance of PTEN and p-Akt co-expression in HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies.
Oncology
; 78(2): 141-9, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20389136
14.
Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial.
Oncology
; 76(1): 49-54, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19039248
15.
P53 and bcl-2 in colorectal cancer arising in patients under 40 years of age: distribution and prognostic relevance.
Eur J Cancer
; 44(9): 1217-22, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18424032
16.
Bone of the hands as unusual metastastatic site of renal cell carcinoma.
J Exp Clin Cancer Res
; 26(4): 595-7, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18365558
17.
Analysis of aneusomy level and HER-2 gene copy number and their effect on amplification rate in breast cancer specimens read as 2+ in immunohistochemical analysis.
Eur J Cancer
; 42(10): 1501-6, 2006 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16762541
18.
Intraperitoneal recombinant alpha-2-interferon alternating with cisplatin as salvage therapy for minimal residual-disease ovarian cancer: a phase II study.
J Clin Oncol
; 8(6): 1036-41, 1990 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-2189953
19.
Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone.
J Clin Oncol
; 9(4): 675-8, 1991 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-1829757
20.
Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group study.
J Clin Oncol
; 13(7): 1649-55, 1995 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-7602354